DDR1 and pancreatic neoplasm: While some of these kinases have been previously identified in kinome or phosphorylome studies of pancreatic cancer (e.g., DDR1 [9], FYN [68]), we classified them as neoteric for the purposes of this discussion because sufficient questions remain as to how these kinases relate to PDAC pathology, treatment, or molecular signaling.